{"id":4515,"date":"2024-02-23T10:04:10","date_gmt":"2024-02-23T00:04:10","guid":{"rendered":"\/eu-uk\/?p=4515"},"modified":"2024-04-19T09:44:22","modified_gmt":"2024-04-18T23:44:22","slug":"4515","status":"publish","type":"post","link":"\/eu-uk\/blog\/2024\/02\/23\/4515\/","title":{"rendered":"Proactive | Interview with CEO Paul Anderson"},"content":{"rendered":"<p>Orthocell CEO Paul Anderson spoke with Jonathan Jackson at Proactive\u00a0about the Company&#8217;s recent strategic placement of $3.5 million, adding prominent investors to the share register.<\/p>\n<p>In the interview, he discusses how ample funding and a strong Board supports the Company as it advances its commercialisation plans for breakthrough nerve repair product, Remplir.<\/p>\n<p>\u201cThis placement enables us now to freely drive these really exciting products &#8211; Remplir, in particular &#8211; into the US market. That takes us well through FDA approval, and really solidifies the position of the Company as we move into those US markets.\u201d<\/p>\n<p><iframe loading=\"lazy\" title=\"YouTube video player\" src=\"https:\/\/www.youtube.com\/embed\/cTFAbMkTNq4?si=KKKbTOesyhyQsMYJ\" width=\"560\" height=\"315\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Orthocell CEO Paul Anderson spoke with Jonathan Jackson at Proactive\u00a0about the Company&#8217;s recent strategic placement of $3.5 million, adding prominent investors to the share register.<\/p>\n","protected":false},"author":2,"featured_media":4549,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[3,1],"tags":[],"class_list":["post-4515","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-media","category-video"],"aioseo_notices":[],"_links":{"self":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/posts\/4515","targetHints":{"allow":["GET"]}}],"collection":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/comments?post=4515"}],"version-history":[{"count":3,"href":"\/eu-uk\/wp-json\/wp\/v2\/posts\/4515\/revisions"}],"predecessor-version":[{"id":4519,"href":"\/eu-uk\/wp-json\/wp\/v2\/posts\/4515\/revisions\/4519"}],"wp:featuredmedia":[{"embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/media\/4549"}],"wp:attachment":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/media?parent=4515"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/categories?post=4515"},{"taxonomy":"post_tag","embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/tags?post=4515"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}